Document is current
Any future updates will be listed below
-
Authors
Liu, Bin https://orcid.org/0000-0002-3168-8456
Petti, Andrew https://orcid.org/0009-0005-8359-8590
Zhou, Xuntao
Cheng, Haoyang https://orcid.org/0000-0003-3313-9853
Gao, Jenny
Yee, Matthew https://orcid.org/0000-0001-5354-9820
Qiao, Youwei
Zhang, Yanjun
Zhou, Lin https://orcid.org/0000-0003-2581-4345
Wolfe, Scot A. https://orcid.org/0000-0002-7042-201X
Jiang, Tingting https://orcid.org/0000-0003-0753-2731
Sontheimer, Erik J. https://orcid.org/0000-0002-0881-0310
- License Information
-
More Information
Article History
Received: 16 June 2025
Accepted: 27 March 2026
First Online: 29 April 2026
Competing interests
: E.J.S. is a co-founder and advisor at Intellia Therapeutics and a scientific advisory board member at Tessera Therapeutics. The University of Massachusetts Chan Medical School and Icahn School of Medicine at Mount Sinai have submitted US provisional patent applications that are currently pending. The other authors declare no competing interests.
